Streetbeat News

Revenues

AMRX

Amneal Pharmaceuticals has reaffirmed its 2023 net revenue outlook of $2.37 billion to $2.42 billion, with an adjusted EPS of $0.51 to $0.58.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:05 am

ENOV

Enovis has announced double-digit growth in its reconstructive business, including an 18% increase in US hip/knee operations in Q3.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 11:03 am

ACMR

ACM Research has updated its revenue guidance for fiscal year 2023 to $520 million to $540 million, a narrower range than the previous $515 million to $585 million. The updated guidance is based on the company's assessment of international trade policy impact, customer spending scenarios, supply chain constraints, and other factors.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:03 am

META

Meta Platforms Inc. (NASDAQ:META) has launched a special bonus program for Instagram content creators in the United States, South Korea, and Japan. The program, which runs until the end of the year, allows creators to earn additional income based on the popularity of their posts, provided they adhere to Meta's content monetization policies. Meta is also enhancing subscription features for creators on both Facebook and Instagram, with over 1 million active subscriptions to Instagram creators and the recent expansion of this feature to 35 new countries.

Portfolio Pulse from Benzinga Neuro

November 07, 2023 | 9:27 am

ADTN

ADTRAN has provided its financial outlook for Q4 2023, expecting revenues to be between $210M and $240M, which is below the consensus of $287.83M. The company also anticipates a non-GAAP operating margin between -7% and 0%.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:24 am

EWU

The U.K. BRC Retail Sales Monitor for October reported a 2.6% increase year-on-year, slightly above the estimated 2.4%, but below the prior 2.8%.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 6:00 am

OPRT

Oportun Financial Corporation has projected its FY23 revenue to be between $1.054 billion and $1.059 billion, slightly above the estimated $1.05 billion.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 10:46 pm

OPRT

Oportun Financial Corporation has projected its Q4 revenue to be between $260M and $265M, which is in line with the estimated $262.56M.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 10:46 pm

GATO

Gatos Silver reported its Q3 revenue of $67 million.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 10:37 pm

AUGX

Augmedix has updated its revenue guidance for 2023, now expecting approximately $44.5 million, up from the previous estimate of $43.73 million.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 10:37 pm